Skip to main content
. 2015 Dec 11;310(3):L224–L231. doi: 10.1152/ajplung.00336.2015

Table 1.

Patient characteristics

Demographics All (n = 259) Nonsurvivors (n = 38) Survivors (n = 221)
Age, (median years, IQR) 5.2 (1.1–13.2) 7.0 (2.3–13.9) 5.0 (1–13.1) P = 0.353
Male (n, %) 143 (55.4) 27 (71.1) 116 (52.7) P = 0.036
Race (n, %)
    Caucasian 166 (64.3) 23 (60.5) 143 (65.0) P = 0.714
    African American 19 (7.4) 4 (11.1) 15 (6.8)
    Asian/Pacific Islander 17 (6.6) 1 (2.8) 16 (7.2)
    Multiple 20 (7.8) 3 (7.9) 17 (7.7)
    American Indian/Alaskan Native 3 (1.2) 1 (2.8) 2 (0.9)
    Unknown 33 (12.8) 6 (16.7) 27 (12.2)
Hispanic/Latino Ethnicity (n, %) 95 (36.8) 14 (38.9) 81 (36.5) P = 0.760
Comorbidities (n, %)
    HCT 25 (9.6) 12 (31.6) 13 (5.9) P < 0.001
ARDS Etiology (n, %)
    Sepsis 56 (21.9) 12 (31.6) 44 (20.1) P = 0.557
    Trauma 13 (5.1) 2 (5.3) 11 (5.1)
    Transfusion 7 (2.7) 1 (2.6) 6 (2.8)
    Other 21 (8.2) 2 (5.3) 19 (8.7)
    Pneumonia 151 (59.0) 21 (55.3) 130 (59.6)
    Aspiration 8 (3.1) 0 (0) 8 (3.7)
Severity of Illness (median, IQR)
    P/F Ratio (n = 221) 110 (77.3–168.6) 106.5 (73.3–128.3) 111.3 (79.3–186.9) P = 0.080
    PRISM-3 (n = 236) 12.5 (7.5–20.5) 20 (12–24) 12 (7–19) P < 0.001

IQR, interquartile range; HCT, hematopoietic cellular transplantation; ARDS, acute respiratory distress syndrome; PRISM-3, Pediatric Risk of Mortality III score.